Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay

Figure 3

Anti-Rpp25 antibodies in samples from anti-Th/To immunoprecipitation (IP)-positive patients, an independent cohort of patients with systemic sclerosis and controls measured by QUANTA Flash anti-Rpp25. Comparative descriptive analysis is shown of samples from anti-Th/To IP-positive patients (n = 8), patients with SSc (n = 70) and controls (n = 367) including patients with rheumatoid arthritis (RA, n = 141), systemic lupus erythematosus (SLE, n = 67), undifferentiated connective tissue disease (UCTD, n = 17), osteoarthritis (OA, n = 47), ankylosing spondylitis (AS, n = 13), polymyalgia rheumatica (PR, n = 20), degenerative spine disease (n = 6), fibromyalgia (n = 5), psoriasis arthritis (n = 13), other pathologies (n = 28) and healthy individuals (HI, n = 10). SE, standard error.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us